InvestorsObserver
Sign Up Login

AVTX Avalo Therapeutics Inc

$9.10 $0.00 (0.00%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall 0

AVTX Stock Analysis Overview

What this means: Avalo Therapeutics Inc (AVTX) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives AVTX a rank of 7. Our methodology considers analysis of the company's financial situation and how it has traded recently. AVTX rank of 7 means that it ranks below 93% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

AVTX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

AVTX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

AVTX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

AVTX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

AVTX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

AVTX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

AVTX Stock Analysis Overview

What this means: Avalo Therapeutics Inc (AVTX) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives AVTX a rank of 7. Our methodology considers analysis of the company's financial situation and how it has traded recently. AVTX rank of 7 means that it ranks below 93% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full AVTX report

Avalo Therapeutics Inc (AVTX) Analyst Forecast

Next 12 months ➝Current Price$9.1052-week High$1296.0052-week Low$7.99FORECAST$0.75-91.76%

AVTX Price, Volume, Earnings, and Dividend Date

  • Last Price $9.10
  • Previous Close $9.10
  • Change $0.00
  • Open $10.17
  • Volume 352,696
  • Avg. Volume (100-day) 246,159
  • Market Cap 7,294,660
  • Days Range 8.36 - 11.16
  • 52-week Range 7.99 - 1296
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 02/07/24
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta -1,298.807
  • PEG Ratio —

Avalo Therapeutics Inc (AVTX) Company Description

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.

Avalo Therapeutics Inc (AVTX) Stock Chart

View Interactive AVTX chart

My Watchlists

Top Stocks in Biotechnology